Ardsley Advisory Partners’s Oxford Immunotec Global PLC Ordinary Shares OXFD Stock Holding History

Ardsley Advisory Partners’s Portfolio OXFD Stock Details OXFD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-10,000	Closed	-$140K	–	184
2017 Q4	$140K	Sell	10,000 -5,000	-33%	-$73.2K	0.02%	131
2017 Q3	$252K	Sell	15,000 -5,000	-25%	-$81.4K	0.03%	117
2017 Q2	$336K	Sell	20,000 -10,000	-33%	-$149K	0.05%	109
2017 Q1	$465K	Hold	30,000	–	–	0.07%	105
2016 Q4	$449K	Sell	30,000 -10,000	-25%	-$140K	0.07%	90
2016 Q3	$502K	Buy	+40,000	New	+$401K	0.08%	92

Other funds holding OXFD

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Polar Capital London, United Kingdom $13.5B AUM 55.9% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

CCM

Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

NLVP

New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return

GPGA

Grandeur Peak Global Advisors Salt Lake City, Utah $427M AUM 39.14% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Ardsley Advisory Partners's OXFD Position: Q1 2018 in Review

Ardsley Advisory Partners sold out of Oxford Immunotec Global PLC Ordinary Shares (OXFD) in Q1 2018, closing a stake of 10,000 shares — an estimated $140K sold.

Ardsley Advisory Partners first reported a position in OXFD in Q3 2016 and held it in 6 quarters. The position peaked at $502K in Q3 2016. 74 funds tracked by Wall St. Rank hold OXFD as of Q1 2018.

Ardsley Advisory Partners reported no remaining Oxford Immunotec Global PLC Ordinary Shares position as of Q1 2018 after selling out during the quarter.
Ardsley Advisory Partners sold 10,000 Oxford Immunotec Global PLC Ordinary Shares shares in Q1 2018, an estimated $140K.
Ardsley Advisory Partners first reported a position in Oxford Immunotec Global PLC Ordinary Shares in Q3 2016 and held it in 6 quarters.
Ardsley Advisory Partners's Oxford Immunotec Global PLC Ordinary Shares position peaked at $502K in Q3 2016.
74 funds tracked by Wall St. Rank held Oxford Immunotec Global PLC Ordinary Shares as of Q1 2018.

Based on Ardsley Advisory Partners's 13F filing for Q1 2018, filed 15 May 2018.